In summary, the above-described findings indicate that regulation of KLF4 by PRMT5-mediated methylation is important for breast cancer development and show that mutating methylation sites of KLF4 and interference in the stability of KLF4 can affect tumor initiation and progression in breast cancer. The gene discussed is PRMT5; the disease is breast carcinoma.